Zhaoqiang Liu

Targeting the entrance channel of NNIBP: Discovery of diarylnicotinamide 1,4-disubstituted 1,2,3-triazoles as novel HIV-1 NNRTIs with high potency against wild-type and E138K mutant virus

Ye Tian, Zhaoqiang Liu, Jinghan Liu et al. · European Journal of Medicinal Chemistry · 2018 · 91 citations · Full text

Medicine, Antiviral Drug Development, Entrance Channel +9

Ginsenoside-Rb1-Mediated Anti-angiogenesis via Regulating PEDF and miR-33a through the Activation of PPAR-γ Pathway

Huixia Lu, Xunian Zhou, Hoi‐Hin Kwok et al. · Frontiers in Pharmacology · 2017 · 70 citations · Full text

PEDF improves atherosclerotic plaque stability by inhibiting macrophage inflammation response

Hao Wen, Minghao Liu, Zhaoqiang Liu et al. · International Journal of Cardiology · 2017 · 52 citations

Inflammation, Vascular Disease, Anti-inflammatory +11

RETRACTED ARTICLE: Ginsenoside-Rg1 enhances angiogenesis and ameliorates ventricular remodeling in a rat model of myocardial infarction

Huiqiu Yin, Zhaoqiang Liu, Fuhai Li et al. · Journal of Molecular Medicine · 2011 · 41 citations

Inflammation, Heart Failure, Angiogenesis +12

Design, synthesis and anti-HIV evaluation of novel diarylnicotinamide derivatives (DANAs) targeting the entrance channel of the NNRTI binding pocket through structure-guided molecular hybridization

Zhaoqiang Liu, Wen‐Ming Chen, Peng Zhan et al. · European Journal of Medicinal Chemistry · 2014 · 40 citations · Full text

Combinatorial Chemistry, Novel Diarylnicotinamide Derivatives, Medicinal Chemistry +11